Compare FuelCell Energy Inc (FCEL) vs Oscar Health Inc (OSCR) Price & Performance

FuelCell Energy (FCEL) trades at $17.245, down 16.49% over 24 hours, reflecting recent volatility amid a securities class action. The stock shows a bullish technical signal with support near $17 and resistance at $19. Fundamentally, the company reported revenue of $158.16 million for 2025 but posted a net loss of $187.90 million, with negative profit margins persisting. Cash flow improved in 2025 with net cash flow of $132.91 million, though operational cash flow remains negative.

The outlook is cautious; while analyst consensus suggests a $21.57 price target with 40% buy ratings, ongoing legal challenges and consistent losses pose significant risks. Investment opportunity hinges on execution turnaround and market adoption of hydrogen energy, but high volatility and financial instability warrant careful consideration.

Oscar Health (OSCR) trades at $32.91, up 1.76% with strong technical momentum and bullish moving average signals. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, with profitability turning positive at $551M net income. Recent earnings beats and raised guidance have driven positive sentiment, though the stock faces challenges from rising medical costs and competitive pressures in the ACA market.

The outlook remains constructive with analyst consensus at $34.00 and strong institutional interest, though investors should monitor execution risks and medical cost trends. The combination of market share gains, margin expansion potential, and bullish technical setup supports further upside if the company can maintain its growth trajectory.